Blake Flood

986 total citations · 1 hit paper
9 papers, 667 citations indexed

About

Blake Flood is a scholar working on Oncology, Infectious Diseases and Immunology. According to data from OpenAlex, Blake Flood has authored 9 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Blake Flood's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and CAR-T cell therapy research (3 papers). Blake Flood is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and CAR-T cell therapy research (3 papers). Blake Flood collaborates with scholars based in United States. Blake Flood's co-authors include Thomas F. Gajewski, Emily F. Higgs, Thomas F. Gajewski, Leticia Corrales, Vyara Matson, Stefani Spranger, Shuyin Li, Jason J. Luke, Ken Hatogai and Jovian Yu and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Immunological Reviews.

In The Last Decade

Blake Flood

7 papers receiving 659 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STING pathway agonism as a cancer therapeutic

2019 259 citations Blake Flood, Emily F. Higgs et al. Immunological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Blake Flood United States	4	496	280	246	92	66	9	667
Emily F. Higgs United States	7	421 0.8×	336 1.2×	207 0.8×	72 0.8×	39 0.6×	15	619
Yongxiang Yan China	8	332 0.7×	356 1.3×	203 0.8×	39 0.4×	46 0.7×	12	619
Kenzo Ohara Japan	12	406 0.8×	274 1.0×	167 0.7×	65 0.7×	27 0.4×	36	553
So Jung Kong South Korea	10	434 0.9×	324 1.2×	236 1.0×	120 1.3×	40 0.6×	16	681
Samuel Alsén Sweden	9	513 1.0×	277 1.0×	191 0.8×	35 0.4×	34 0.5×	15	737
J Filderman United States	5	411 0.8×	234 0.8×	191 0.8×	77 0.8×	37 0.6×	7	532
Zhengkui Zhang China	12	375 0.8×	227 0.8×	562 2.3×	73 0.8×	64 1.0×	17	864
Timo Reisländer Germany	5	224 0.5×	282 1.0×	223 0.9×	33 0.4×	83 1.3×	10	494
Simon Yue United States	14	522 1.1×	271 1.0×	165 0.7×	48 0.5×	25 0.4×	17	709
Tetje C. van der Sluis Netherlands	12	609 1.2×	467 1.7×	196 0.8×	43 0.5×	51 0.8×	16	815

Countries citing papers authored by Blake Flood

Since Specialization

Citations

This map shows the geographic impact of Blake Flood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake Flood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake Flood more than expected).

Fields of papers citing papers by Blake Flood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake Flood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake Flood. The network helps show where Blake Flood may publish in the future.

Co-authorship network of co-authors of Blake Flood

This figure shows the co-authorship network connecting the top 25 collaborators of Blake Flood. A scholar is included among the top collaborators of Blake Flood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake Flood. Blake Flood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Li, Shuyin, Jason W. Shapiro, Hardik Shah, et al.. (2024). Abstract 5350: Decr2 regulates tumor cell ferroptosis and immunotherapy efficacy. Cancer Research. 84(6_Supplement). 5350–5350. 1 indexed citations

2.

Higgs, Emily F., Blake Flood, Athalia R. Pyzer, et al.. (2022). Insights from a Rapidly Implemented COVID-19 Biobank Using Electronic Consent and Informatics Tools. Biopreservation and Biobanking. 21(2). 166–175.

3.

Reschke, Robin, Jovian Yu, Blake Flood, et al.. (2021). Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. Journal for ImmunoTherapy of Cancer. 9(9). e003521–e003521. 98 indexed citations

4.

Chen, Xiufen, Brendan W. MacNabb, Blake Flood, Bruce R. Blazar, & Justin Kline. (2021). Divergent fates of antigen-specific CD8+ T cell clones in mice with acute leukemia. Cell Reports. 37(6). 109991–109991. 5 indexed citations

5.

Cabanov, Alexandra, Blake Flood, Jeffrey Bloodworth, et al.. (2020). Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection. Clinical Cancer Research. 26(18).

6.

Cabanov, Alexandra, Blake Flood, Jeffrey Bloodworth, et al.. (2020). Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection. Clinical Cancer Research. 26(18_Supplement). S04–2. 1 indexed citations

7.

Gajewski, Thomas F., Emily F. Higgs, Shuyin Li, Blake Flood, & Ken Hatogai. (2020). 239 Decr2 loss promotes resistance of tumor cells to immunotherapy by affecting CD8+ T cell-regulated tumor ferroptosis. Regular and Young Investigator Award Abstracts. A142.1–A142. 1 indexed citations

8.

Flood, Blake, Emily F. Higgs, Shuyin Li, Jason J. Luke, & Thomas F. Gajewski. (2019). STING pathway agonism as a cancer therapeutic. Immunological Reviews. 290(1). 24–38. 259 indexed citations breakdown →

9.

Corrales, Leticia, Vyara Matson, Blake Flood, Stefani Spranger, & Thomas F. Gajewski. (2016). Innate immune signaling and regulation in cancer immunotherapy. Cell Research. 27(1). 96–108. 302 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact